FDA Inspection 1078708 — Haemonetics Corporation
The FDA completed an inspection of Haemonetics Corporation on Dec 20, 2018 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 20, 2018
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
Sponsor, Contract Research Organization